These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9679924)

  • 21. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
    Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
    J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
    Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.
    van den Berg A; Hulsbeek MF; de Jong D; Kok K; Veldhuis PM; Roche J; Buys CH
    Genes Chromosomes Cancer; 1996 Jan; 15(1):64-72. PubMed ID: 8824727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic alterations in renal tumors: a study of 38 Southeast Asian patients.
    Lau LC; Tan PH; Chong TW; Foo KT; Yip S
    Cancer Genet Cytogenet; 2007 May; 175(1):1-7. PubMed ID: 17498551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.
    Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G
    Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma.
    Cheng L; MacLennan GT; Zhang S; Wang M; Zhou M; Tan PH; Foster S; Lopez-Beltran A; Montironi R
    Clin Cancer Res; 2008 Dec; 14(24):8087-93. PubMed ID: 19088024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
    Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
    Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving classification of renal cell neoplasia.
    Delahunt B; Velickovic M; Grebe SK
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases.
    Hes O; Brunelli M; Michal M; Cossu Rocca P; Hora M; Chilosi M; Mina M; Boudova L; Menestrina F; Martignoni G
    Ann Diagn Pathol; 2006 Jun; 10(3):133-9. PubMed ID: 16730306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Jan; 9(1):52-8. PubMed ID: 12538451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
    Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
    J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.